Vivacta Bio Company
Vivacta Bio develops in vivo CAR-T cell therapies for cancer and autoimmune diseases.
Employee Number:
51-100
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2025-01-01
Industry:
Advanced Longevity (R&D)
Sub-Industry:
Gene Therapies (Age related diseases treatment)
Investors:
Qiming Venture Partners, Decheng Capital, Loyal Valley Capital, OrbiMed, Apricot Capital
Ipo Status:
private
City:
Shanghai
Region:
Shanghai
Country:
China